Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2019

01-11-2019 | Glaucoma | Glaucoma

Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection

Authors: Jocelyn Lam, Ian Luttrell, Leona Ding, Kasra Rezaei, Jennifer R. Chao, Yewlin Chee, Lisa C. Olmos De Koo, Joanne C. Wen

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2019

Login to get access

Abstract

Background

To characterize how prior incisional glaucoma surgery affects the intraocular pressure (IOP) elevation immediately following intravitreal anti-VEGF injections (IVI).

Methods

Single institution, experimental study. Patients with a history of incisional glaucoma surgery who were receiving anti-VEGF injections were recruited as well as control eyes. Pre- and post-injection IOP measurements were compared as well as time to recovery to within 5 and 10 mmHg of baseline IOP.

Results

Ten eyes with a history of glaucoma surgery and 29 control eyes receiving anti-VEGF injections were included. The most common indication for intravitreal anti-VEGF injection was proliferative diabetic retinopathy in both surgical and control eyes (50% vs 45%, p = 1.00). Post-injection IOP was significantly decreased compared to baseline IOP after anti-VEGF injection in surgical versus control eyes (26.5 ± 8.9 mmHg vs 44.2 ± 8.5 mmHg, respectively, p < 0.001). The mean change in IOP following intravitreal anti-VEGF injection was lower in surgical eyes (10.7 ± 6.6 mmHg vs 28.6 ± 8.3 mmHg, p < 0.001). The mean time for the IOP to return to within 10 mmHg of pre-injection IOP was less in surgical eyes (5.2 ± 4.1 min vs 13.3 ± 7.6 min, p = 0.002).

Conclusions

Eyes with prior incisional glaucoma surgery demonstrated a significantly lower post-injection IOP elevation and a faster recovery to within 10 mmHg of their pre-injection IOP. Incisional glaucoma surgery may be considered for patients where the attenuation of post-injection IOP elevation is needed and other less invasive measures have failed.
Literature
1.
go back to reference Lee JW, Park H, Choi JH et al (2016) Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab. BMC Ophthalmol 16:69CrossRef Lee JW, Park H, Choi JH et al (2016) Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab. BMC Ophthalmol 16:69CrossRef
2.
go back to reference Kim JE, Mantravadi AV, Hur EY, Covert DJ (2008) Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 146(6):930–934.e1CrossRef Kim JE, Mantravadi AV, Hur EY, Covert DJ (2008) Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 146(6):930–934.e1CrossRef
3.
go back to reference Gismondi M, Salati C, Salvetat ML, Zeppieri M, Brusini P (2009) Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 18(9):658–661CrossRef Gismondi M, Salati C, Salvetat ML, Zeppieri M, Brusini P (2009) Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 18(9):658–661CrossRef
4.
go back to reference Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J (2007) Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 42(6):807–811CrossRef Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J (2007) Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 42(6):807–811CrossRef
5.
go back to reference Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB (2018) The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol 63(3):281–295CrossRef Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB (2018) The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol 63(3):281–295CrossRef
6.
go back to reference Falkenstein IA, Cheng L, Freeman WR (2007) Changes of intraocular pressure after intravitreal injection of bevacizumab (AVASTIN). Retina. 27(8):1044–1047CrossRef Falkenstein IA, Cheng L, Freeman WR (2007) Changes of intraocular pressure after intravitreal injection of bevacizumab (AVASTIN). Retina. 27(8):1044–1047CrossRef
7.
go back to reference Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye. 23(1):181–185CrossRef Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye. 23(1):181–185CrossRef
8.
go back to reference Zhi Z, Cepurna WO, Johnson EC, Morrison JC, Wang RK (2012) Impact of intraocular pressure on changes of blood flow in the retina, choroid, and optic nerve head in rats investigated by optical microangiography. Biomed Opt Express 3(9):2220–2233CrossRef Zhi Z, Cepurna WO, Johnson EC, Morrison JC, Wang RK (2012) Impact of intraocular pressure on changes of blood flow in the retina, choroid, and optic nerve head in rats investigated by optical microangiography. Biomed Opt Express 3(9):2220–2233CrossRef
9.
go back to reference Iwase T, Akahori T, Yamamoto K, Ra E, Terasaki H (2018) Evaluation of optic nerve head blood flow in response to increase of intraocular pressure. Sci Rep 8(1):17235CrossRef Iwase T, Akahori T, Yamamoto K, Ra E, Terasaki H (2018) Evaluation of optic nerve head blood flow in response to increase of intraocular pressure. Sci Rep 8(1):17235CrossRef
10.
go back to reference Shirakashi M (2009) The effects of intraocular pressure elevation on optic nerve axonal transport in the monkey. Acta Ophthalmol 68(1):37–43CrossRef Shirakashi M (2009) The effects of intraocular pressure elevation on optic nerve axonal transport in the monkey. Acta Ophthalmol 68(1):37–43CrossRef
11.
go back to reference Liu X, Li M, Zhong Y, Xiao H, Huang J, Mao Z (2011) The damage patterns of retinal nerve fiber layer in acute and chronic intraocular pressure elevation in primary angle closure glaucoma. Eye Sci 26(3):154–160PubMed Liu X, Li M, Zhong Y, Xiao H, Huang J, Mao Z (2011) The damage patterns of retinal nerve fiber layer in acute and chronic intraocular pressure elevation in primary angle closure glaucoma. Eye Sci 26(3):154–160PubMed
12.
go back to reference Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F et al (2012) Retinal nerve Fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal Ranibizumab. Invest Opthalmol Vis Sci 53(10):6214CrossRef Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F et al (2012) Retinal nerve Fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal Ranibizumab. Invest Opthalmol Vis Sci 53(10):6214CrossRef
13.
go back to reference Soheilian M, Karimi S, Montahae T, Nikkhah H, Mosavi SA (2017) Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. Graefes Arch Clin Exp Ophthalmol 255(9):1705–1712CrossRef Soheilian M, Karimi S, Montahae T, Nikkhah H, Mosavi SA (2017) Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. Graefes Arch Clin Exp Ophthalmol 255(9):1705–1712CrossRef
14.
go back to reference Theoulakis PE, Lepidas J, Petropoulos IK, Livieratou A, Brinkmann CK, Katsimpris JM (2010) Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monatsbl Augenheilkd 227(4):280–284CrossRef Theoulakis PE, Lepidas J, Petropoulos IK, Livieratou A, Brinkmann CK, Katsimpris JM (2010) Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monatsbl Augenheilkd 227(4):280–284CrossRef
15.
go back to reference Ozcaliskan S, Ozturk F, Yilmazbas P, Beyazyildiz O (2015) Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection. Int J Ophthalmol 8(3):496–500PubMedPubMedCentral Ozcaliskan S, Ozturk F, Yilmazbas P, Beyazyildiz O (2015) Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection. Int J Ophthalmol 8(3):496–500PubMedPubMedCentral
17.
go back to reference Frenkel MPC, Haji SA, Frenkel REP (2010) Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections. Arch Ophthalmol 128(12):1523–1527CrossRef Frenkel MPC, Haji SA, Frenkel REP (2010) Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections. Arch Ophthalmol 128(12):1523–1527CrossRef
18.
go back to reference Katayama BYNY, Bianka YN, Bonini-Filho MA et al (2014) Comparison of acetazolamide, Brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection. J Glaucoma 23(7):461–463CrossRef Katayama BYNY, Bianka YN, Bonini-Filho MA et al (2014) Comparison of acetazolamide, Brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection. J Glaucoma 23(7):461–463CrossRef
19.
go back to reference Murray CD, Wood D, Allgar V, Walters G, Gale RP (2014) Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. Eye. 28(10):1218–1222CrossRef Murray CD, Wood D, Allgar V, Walters G, Gale RP (2014) Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. Eye. 28(10):1218–1222CrossRef
20.
go back to reference Ichiyama Y, Sawada T, Kakinoki M et al (2014) Anterior chamber paracentesis might prevent sustained intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration. Ophthalmic Res 52(4):234–238CrossRef Ichiyama Y, Sawada T, Kakinoki M et al (2014) Anterior chamber paracentesis might prevent sustained intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration. Ophthalmic Res 52(4):234–238CrossRef
21.
go back to reference Carnota-Méndez P, Méndez-Vázquez C, Otero-Villar J, Saavedra-Pazos JA (2014) Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs. Eur J Ophthalmol 24(5):771–777CrossRef Carnota-Méndez P, Méndez-Vázquez C, Otero-Villar J, Saavedra-Pazos JA (2014) Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs. Eur J Ophthalmol 24(5):771–777CrossRef
22.
go back to reference Eadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS (2017) Association of Repeated Intravitreous Bevacizumab Injections with Risk for Glaucoma surgery. JAMA Ophthalmol 135(4):363–368CrossRef Eadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS (2017) Association of Repeated Intravitreous Bevacizumab Injections with Risk for Glaucoma surgery. JAMA Ophthalmol 135(4):363–368CrossRef
23.
go back to reference Kim G-N, Han Y-S, Chung I-Y, Seo S-W, Park J-M, Yoo J-M (2013) Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension. Semin Ophthalmol 28(2):61–67CrossRef Kim G-N, Han Y-S, Chung I-Y, Seo S-W, Park J-M, Yoo J-M (2013) Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension. Semin Ophthalmol 28(2):61–67CrossRef
24.
go back to reference Knip MM, Välimäki J (2012) Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study. Acta Ophthalmol 90(3):254–258CrossRef Knip MM, Välimäki J (2012) Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study. Acta Ophthalmol 90(3):254–258CrossRef
25.
go back to reference Alaghband P, Beltran-Agulló L, Galvis EA, Overby DR, Lim KS (2018) Effect of phacoemulsification on facility of outflow. Br J Ophthalmol 102(11):1520–1526CrossRef Alaghband P, Beltran-Agulló L, Galvis EA, Overby DR, Lim KS (2018) Effect of phacoemulsification on facility of outflow. Br J Ophthalmol 102(11):1520–1526CrossRef
Metadata
Title
Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Authors
Jocelyn Lam
Ian Luttrell
Leona Ding
Kasra Rezaei
Jennifer R. Chao
Yewlin Chee
Lisa C. Olmos De Koo
Joanne C. Wen
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2019
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-019-04431-x

Other articles of this Issue 11/2019

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2019 Go to the issue